Lightstone Ventures Revenue and Competitors

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Lightstone Ventures's estimated annual revenue is currently $15M per year.(i)
  • Lightstone Ventures's estimated revenue per employee is $714,286

Employee Data

  • Lightstone Ventures has 21 Employees.(i)
  • Lightstone Ventures grew their employee count by -19% last year.

Lightstone Ventures's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
CEO Lightstone Singapore PTE. LTD.Reveal Email/Phone
3
CFO & CCOReveal Email/Phone
4
General PartnerReveal Email/Phone
5
General PartnerReveal Email/Phone
6
Venture PartnerReveal Email/Phone
7
Executive AssistantReveal Email/Phone
8
General PartnerReveal Email/Phone
9
Senior Fund AccountantReveal Email/Phone
10
PrincipalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M10-55%N/AN/A
#2
N/A35-3%N/AN/A
#3
$7.5M8-27%N/AN/A
#4
$3.5M7952%N/AN/A
#5
N/A110%N/AN/A
#6
$7.5M29-12%N/AN/A
#7
$15M43-16%N/AN/A
#8
$15M34N/AN/AN/A
#9
$7.5M2624%N/AN/A
#10
$15M24518%N/AN/A
Add Company

What Is Lightstone Ventures?

Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and medtech companies pioneering the big ideas poised to transform patient outcomes. We were founded in 2012 to empower visionary entrepreneurs with the resources and operational guidance necessary bring innovative therapeutics and technologies to the people who need them most. Our investment team has led deals resulting in 19 acquisitions and 20 initial public offerings over the last two decades. We have offices in Boston, Mass., Menlo Park, Calif., Dublin, Ireland and Singapore. For more information, visit www.lightstonevc.com.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$15M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lightstone Ventures News

2022-04-20 - Catamaran Bio Appoints Cherry Thomas, MD, as Chief Medical Officer

... Sofinnova Partners, Lightstone Ventures, Takeda Ventures, Astellas Venture Management, and the UMN Discovery Capital investment program.

2022-04-13 - Leadership transition at Cerevance

Cerevance was launched by Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) and Lightstone Ventures in December 2016.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M210%N/A
#2
$2.1M21-22%N/A
#3
$2.1M21N/AN/A
#4
$7.5M215%$390.1M
#5
$7.4M2124%$156M